Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist.
about
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Study design and population ph ...... rleukin-1 receptor antagonist.
@en
type
label
Study design and population ph ...... rleukin-1 receptor antagonist.
@en
prefLabel
Study design and population ph ...... rleukin-1 receptor antagonist.
@en
P2093
P2860
P1476
Study design and population ph ...... rleukin-1 receptor antagonist.
@en
P2093
James Galea
Kayode Ogungbenro
Nancy Rothwell
Sharon Hulme
Stephen Hopkins
P2860
P2888
P356
10.1007/S10928-015-9450-0
P577
2015-10-18T00:00:00Z